Models to inform neutralizing antibody therapy strategies during pandemics: the case of SARS-CoV-2

BACKGROUND: Neutralizing antibodies (nAbs) against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) can play an important role in reducing impacts of the COVID-19 pandemic, complementing ongoing public health efforts such as diagnostics and vaccination. Rapidly designing, manufacturing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guttieres, Donovan, Sinskey, Anthony J, Springs, Stacy L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022923/
https://www.ncbi.nlm.nih.gov/pubmed/33928236
http://dx.doi.org/10.1093/abt/tbab006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022923/
https://www.ncbi.nlm.nih.gov/pubmed/33928236
http://dx.doi.org/10.1093/abt/tbab006

Ejemplares similares